VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 715 filers reported holding VANECK VECTORS ETF TR in Q4 2020. The put-call ratio across all filers is 1.18 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,605,401 | +8.6% | 59,658 | +21.6% | 0.06% | +13.2% |
| Q2 2023 | $1,477,696 | +35.5% | 49,076 | +45.6% | 0.05% | +47.2% |
| Q1 2023 | $1,090,525 | -17.4% | 33,710 | -26.8% | 0.04% | -23.4% |
| Q4 2022 | $1,320,048 | +111.9% | 46,058 | +78.2% | 0.05% | +95.8% |
| Q3 2022 | $623,000 | -23.0% | 25,839 | -12.6% | 0.02% | -14.3% |
| Q2 2022 | $809,000 | -60.6% | 29,552 | -44.8% | 0.03% | -54.1% |
| Q1 2022 | $2,052,000 | +118.3% | 53,501 | +82.2% | 0.06% | +134.6% |
| Q4 2021 | $940,000 | -35.2% | 29,358 | -40.3% | 0.03% | -40.9% |
| Q3 2021 | $1,450,000 | +10.0% | 49,192 | +26.8% | 0.04% | +12.8% |
| Q2 2021 | $1,318,000 | -31.2% | 38,790 | -34.2% | 0.04% | -36.1% |
| Q1 2021 | $1,916,000 | -23.4% | 58,964 | -15.1% | 0.06% | -28.2% |
| Q4 2020 | $2,501,000 | -47.0% | 69,436 | -42.4% | 0.08% | -54.5% |
| Q3 2020 | $4,719,000 | +142.9% | 120,494 | +127.5% | 0.19% | +120.0% |
| Q2 2020 | $1,943,000 | +114.2% | 52,959 | +34.6% | 0.08% | +57.4% |
| Q1 2020 | $907,000 | -66.6% | 39,353 | -57.6% | 0.05% | -53.0% |
| Q4 2019 | $2,717,000 | +21.5% | 92,782 | +10.8% | 0.12% | +7.5% |
| Q3 2019 | $2,236,000 | -16.8% | 83,708 | -20.4% | 0.11% | -23.0% |
| Q2 2019 | $2,689,000 | +60.5% | 105,219 | +40.8% | 0.14% | +46.3% |
| Q1 2019 | $1,675,000 | +47.6% | 74,723 | +38.9% | 0.10% | +14.5% |
| Q4 2018 | $1,135,000 | +52.3% | 53,793 | +33.7% | 0.08% | +88.6% |
| Q3 2018 | $745,000 | -25.6% | 40,234 | -10.3% | 0.04% | -34.3% |
| Q2 2018 | $1,001,000 | +4.8% | 44,869 | +3.2% | 0.07% | -4.3% |
| Q1 2018 | $955,000 | +15.9% | 43,468 | +22.7% | 0.07% | +11.1% |
| Q4 2017 | $824,000 | +0.1% | 35,439 | -1.2% | 0.06% | -7.4% |
| Q3 2017 | $823,000 | +7.2% | 35,860 | +3.1% | 0.07% | -5.6% |
| Q2 2017 | $768,000 | +9.4% | 34,768 | +13.0% | 0.07% | +5.9% |
| Q1 2017 | $702,000 | -7.3% | 30,779 | -15.0% | 0.07% | -18.1% |
| Q4 2016 | $757,000 | -35.6% | 36,209 | -18.5% | 0.08% | -40.3% |
| Q3 2016 | $1,175,000 | -27.9% | 44,455 | -24.4% | 0.14% | -34.4% |
| Q2 2016 | $1,630,000 | – | 58,805 | – | 0.21% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Harbor Financial Group, LLC | 1,221,955 | $36,011,000 | 14.81% |
| New Harbor Financial Group, LLC | 1,155,900 | $34,064,000 | 14.01% |
| Memorial Sloan Kettering Cancer Center | 738,500 | $21,764,000 | 13.56% |
| Hollow Brook Wealth Management LLC | 670,275 | $19,753,000 | 12.24% |
| Grand Central Investment Group | 293,243 | $8,642,000 | 11.46% |
| BW Gestao de Investimentos Ltda. | 940,800 | $27,725,000 | 8.44% |
| Slate Path Capital LP | 5,930,000 | $174,757,000 | 7.97% |
| Nokomis Capital, L.L.C. | 512,628 | $15,107,000 | 7.14% |
| Plaisance Capital LLC | 288,000 | $8,487,000 | 6.05% |
| Guild Investment Management, Inc. | 200,114 | $5,897,000 | 5.68% |